You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 1
  • 4CPS-017 Real-world evidence on rheumatoid arthritis treatment persistence: janus kinase inhibitors versus biologic disease-modifying antirheumatic drugs

Article info

Article menu

Download PDFPDF

Late breaking abstracts
4CPS-017 Real-world evidence on rheumatoid arthritis treatment persistence: janus kinase inhibitors versus biologic disease-modifying antirheumatic drugs
Free

Authors

Citation

Martinez-Molina C, Soares Pereira Batista C, Park H, et al
4CPS-017 Real-world evidence on rheumatoid arthritis treatment persistence: janus kinase inhibitors versus biologic disease-modifying antirheumatic drugs
European Journal of Hospital Pharmacy 2023;30:A181.

Publication history

  • First published May 2, 2023.
Online issue publication 
May 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.